These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 27228479
1. Prognostic utility of combination of NT-proBNP with high sensitive cTn I in patients with heart failure: Results from retrospective study in an emergency department. Cheng H, Fan WZ, Wang SC, Geng J, Zang HL, Shen XH, Liu ZH, Wang LZ. Scand J Clin Lab Invest; 2016 Sep; 76(5):361-7. PubMed ID: 27228479 [Abstract] [Full Text] [Related]
2. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP. Leto L, Testa M, Feola M. Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781 [Abstract] [Full Text] [Related]
3. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study. Eurlings LW, Sanders-van Wijk S, van Kraaij DJ, van Kimmenade R, Meeder JG, Kamp O, van Dieijen-Visser MP, Tijssen JG, Brunner-La Rocca HP, Pinto YM. J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696 [Abstract] [Full Text] [Related]
10. [The prognostic role of extremely high levels of the B-type natriuretic prohormone with regard to the in-hospital mortality of patients hospitalized for heart failure]. Bózsik B, Nagy E, Somlói M, Tomcsányi J. Orv Hetil; 2017 May; 158(20):779-782. PubMed ID: 28502208 [Abstract] [Full Text] [Related]
11. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction. Huang A, Qi X, Hou W, Qi Y, Zhao N, Liu K. Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719 [Abstract] [Full Text] [Related]